Standout Papers

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial 2000 2026 2008 2017 3.1k
  1. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial (2002)
    Stephen B. Hanauer, Brian G. Feagan et al. The Lancet
  2. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis (2005)
    Paul Rutgeerts, William J. Sandborn et al. New England Journal of Medicine
  3. Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease (2010)
    Jean‐Frédéric Colombel, William J. Sandborn et al. New England Journal of Medicine
  4. Infliximab Maintenance Therapy for Fistulizing Crohn's Disease (2004)
    Bruce E. Sands, Frank Anderson et al. New England Journal of Medicine
  5. A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 (2000)
    Christoph Gasché, Jürgen Schölmerich et al. Inflammatory Bowel Diseases
  6. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. (1989)
    Daniel Rachmilewitz BMJ
  7. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease (2004)
    Paul Rutgeerts, Brian G. Feagan et al. Gastroenterology
  8. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis (2004)
    Daniel Rachmilewitz, Kyoko Katakura et al. Gastroenterology
  9. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. (1978)
    P. Sharon, M. Ligumsky et al. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)

Immediate Impact

8 by Nobel laureates 9 from Science/Nature 237 standout
Sub-graph 1 of 12

Citing Papers

Crohn's disease
2024 Standout
Ulcerative Colitis in Adults
2023 Standout
281 intermediate papers

Works of Daniel Rachmilewitz being referenced

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
and 38 more

Author Peers

Author Last Decade Papers Cites
Daniel Rachmilewitz 6122 13437 10262 196 21.1k
Antoine Cortot 5930 11509 8183 274 19.0k
Walter Reinisch 5093 13684 10707 334 19.2k
Julián Panés 8255 13720 10880 570 25.1k
Stephen B. Hanauer 6145 18615 14207 398 24.1k
María T. Abreu 4878 9734 7129 365 20.7k
Axel Dignaß 4949 9666 6862 272 16.7k
Jean–Frédéric Colombel 3644 8733 6489 205 13.9k
Sander J. H. van Deventer 4858 7589 7651 267 21.8k
Eduard F. Stange 5314 8122 5849 284 18.0k
Stephan R. Targan 5869 17995 12274 428 30.4k

All Works

Loading papers...

Rankless by CCL
2026